Method for improving type I active oxygen efficiency of aggregation-induced emission type photosensitizer and application of AIE photosensitizer nano polymer

By synthesizing AIE photosensitizers with optimized electron donors and encapsulating them in amphiphilic polymer liposomes, the method enhances ROS generation in low-oxygen environments, addressing the inefficiency of traditional photosensitizers and effectively inhibiting tumor growth.

CN119074919AInactive Publication Date: 2024-12-06NANCHANG HANGKONG UNIVERSITY
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202411209091.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-30
Publication Date
2024-12-06
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The efficiency of reactive oxygen species (ROS) generation by traditional photosensitizers is reduced in low-oxygen environments due to tumor hypoxia, limiting the effectiveness of photodynamic therapy in cancer treatment.

Method used

A method involving the synthesis of aggregation-induced emission (AIE) photosensitizers, optimized with intramolecular electron donors and acceptors, encapsulated in amphiphilic polymer liposomes to enhance type I ROS generation, reducing reliance on oxygen.

Benefits of technology

The AIE photosensitizer nanopolymer exhibits improved ROS generation efficiency, including type I free radical ROS, with enhanced biocompatibility and photostability, effectively inhibiting tumor growth in vitro and in vivo.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119074919A_ABST
    Figure CN119074919A_ABST
Patent Text Reader

Abstract

The invention discloses a method for improving type I active oxygen efficiency of an aggregation-induced emission type photosensitizer and application of an AIE photosensitizer nano polymer, and belongs to the technical field of photosensitizer materials. The invention provides a method for improving the efficiency of I-type active oxygen of an aggregation-induced emission type photosensitizer. The improvement of free radical type ROS (reactive oxygen species) efficiency is realized in molecular design and polymer formation respectively. In the molecular design level, generation of II-type singlet oxygen is inhibited by optimizing an electron donor and an electron acceptor, so that generation of free radical type ROS is promoted. The hydrophilic photosensitizer polymer is formed by coating a small-molecule photosensitizer with amphiphilic high-molecular lipidosome at the formation level of the polymer, so that the efficiency of singlet oxygen generated by original small molecules is inhibited, and the generation of I-type ROS is further promoted.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of photosensitizer materials, and in particular relates to a method for improving the efficiency of type I active oxygen of aggregation-induced emission photosensitizer and the application of AIE photosensitizer nanopolymers. Background Art

[0002] Photodynamic therapy (PDT) has unique advantages such as non-invasive / minimally invasive, strong controllability, good efficacy and low resistance to drug resistance. It has important application value in clinical aspects such as cancer treatment, wound healing and skin infection prevention. Photosensitizer, oxygen and excitation light source are three important components in photodynamic therapy. The photosensitizer is irradiated with appropriate excitation light to excite the generation of triplet energy, which then interacts with oxygen to produce reactive oxygen species (ROS). The generated ROS can effectively kill cancer cells and bacteria, thereby achieving the effect of treating diseases. However, due to the typical tumor hypoxia caused by abnormal proliferation, apoptosis and tumor vascular malformations of tumor cells, the efficiency of ROS generated by photosensitizers in tumors is reduced, which seriously affects the therapeutic effect of PDT. Therefore, the design and synthesis of new photosensitizers with low oxygen dependence to achieve the behavior of generating high-efficiency ROS in a low-oxygen environment is expected to solve the problem of inefficient photodynamic therapy of tumors by traditional photosensitizers.

[0003] ROS can be divided into two categories. One is singlet oxygen, which is mainly based on energy transfer and has a high oxygen dependence problem, while the other is type I ROS, which is mainly based on electron transfer and can still efficiently generate free radical ROS even at low oxygen concentrations. For this reason, the precise design of type I photosensitizers and improving their efficiency in generating free radical ROS has become an important research direction. Therefore, a method that can improve the efficiency of type I reactive oxygen species of aggregation-induced emission photosensitizers is urgently needed to solve the above problems. Summary of the invention

[0004] In order to solve the above technical problems, the present invention proposes a method for improving the efficiency of type I active oxygen of aggregation-induced emission photosensitizer and the application of AIE photosensitizer nanopolymer.

[0005] To achieve the above object, the present invention provides the following technical solutions:

[0006] The present invention provides a method for improving the efficiency of type I active oxygen of an aggregation-induced emission photosensitizer, comprising the following steps:

[0007] (1) dissolving 4,7-dibromo-2,1,3-benzothiadiazole or 4,7-dibromo-2,1,3-benzoselenadiazole with a triphenylamine derivative, a catalyst and a base in a mixed solution of an organic solvent and water to carry out a Suzuki reaction, followed by refluxing, extraction, washing, drying and column chromatography to obtain an aggregation-induced emission photosensitizer;

[0008] (2) dissolving the aggregation-induced emission photosensitizer and the amphiphilic polymer liposome obtained in step (1) in an organic solvent to obtain a mixed solution; mixing the obtained mixed solution with water, performing ultrasonic treatment, and then stirring and filtering to obtain an AIE photosensitizer nanopolymer.

[0009] The present invention provides a method for improving the efficiency of type I reactive oxygen species of aggregation-induced luminescence photosensitizers, and improves the efficiency of free radical ROS in molecular design and polymer formation. At the molecular design level, the generation of type II singlet oxygen is suppressed by optimizing electron donors and electron acceptors, thereby promoting the generation of free radical ROS. At the polymer formation level, amphiphilic polymer liposomes are used to encapsulate small molecule photosensitizers to form hydrophilic photosensitizer polymers, and the efficiency of singlet oxygen generated by the original small molecules is suppressed, and further promoting the generation of type I ROS.

[0010] Preferably, in step (1), the molar ratio of the 4,7-dibromo-2,1,3-benzothiadiazole or 4,7-dibromo-2,1,3-benzoselenadiazole to the triphenylamine derivative, the catalyst and the base is (1-1.5):(2-4):(0.05-0.1):15.

[0011] Furthermore, in step (1), the molar ratio of the 4,7-dibromo-2,1,3-benzothiadiazole, the triphenylamine derivative, the catalyst and the base is 1.5:3.4:0.06:15.

[0012] Preferably, in step (1), the triphenylamine derivative includes one of 4-boric acid triphenylamine and 4-boric acid-4',4'-dimethoxytriphenylamine.

[0013] Preferably, in step (1), the catalyst is tetrakistriphenylphosphine palladium; the base is one of K2CO3 and Na2CO3, more preferably K2CO3.

[0014] Furthermore, in step (1), the volume ratio of the organic solvent to water in the mixture of the organic solvent and water is 5:1.

[0015] Preferably, in step (1), the temperature of the Suzuki reaction is 80-100° C. and the time is 10-14 h.

[0016] Furthermore, in step (1), the temperature of the Suzuki reaction is 100° C. and the time is 12 h.

[0017] Furthermore, in step (1), the reflux time is 12 hours, the reflux atmosphere is nitrogen; the extraction agent is dichloromethane (DCM), and the number of extractions is three times; the washing reagent is saline; the drying agent is anhydrous sodium sulfate; the eluent for column chromatography is dichloromethane and petroleum ether, and the volume ratio of dichloromethane to petroleum ether is 1:30.

[0018] Preferably, in step (2), the mass ratio of the aggregation-induced emission photosensitizer to the amphiphilic polymer liposome is 1:2.

[0019] Furthermore, in step (2), the amphiphilic polymer liposome is DSPE-PEG 2000 .

[0020] Preferably, in step (2), the stirring time is 36 hours.

[0021] Preferably, in step (2), the volume ratio of the organic solvent to water is 1:10.

[0022] Furthermore, in step (2), the ultrasonic treatment time is 5 minutes.

[0023] Furthermore, in step (1) or step (2), the organic solvent is one of tetrahydrofuran and toluene.

[0024] The present invention provides an AIE photosensitizer nanopolymer, which is prepared according to the method for improving the efficiency of type I active oxygen of aggregation-induced emission photosensitizer described in the above technical scheme.

[0025] The present invention also provides the use of the AIE photosensitizer nanopolymer described in the above technical solution in the preparation of tumor treatment drugs.

[0026] Compared with the prior art, the present invention has the following advantages and technical effects:

[0027] The present invention obtains an organic type I photosensitizer with bright solid-state luminescence, large Stokes shift and better photostability by optimizing intramolecular electron donors and electron acceptors, and further encapsulates the above organic type I photosensitizer with amphiphilic polymer liposomes. The prepared AIE photosensitizer nanopolymer not only has good water dispersibility, but also further improves the efficiency of the photosensitizer in generating type I ROS.

[0028] The in vitro cell fluorescence imaging results of the present invention show that DMTBSZ NPs and DMTBSeZ NPs can be rapidly engulfed by cells and display bright red fluorescence, and can also effectively produce 1 O2, O2 ·-The results of cytotoxicity evaluation showed that DMTBSZ NPs had good biocompatibility with cells without white light irradiation, but most cancer cells were killed after irradiation with white light of appropriate power. The results of in vivo tumor experiments showed that DMTBSZ NPs could effectively inhibit the growth of tumors in mice. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] The drawings constituting a part of the present application are used to provide a further understanding of the present application. The illustrative embodiments and descriptions of the present application are used to explain the present application and do not constitute an improper limitation on the present application. In the drawings:

[0030] Figure 1 The synthetic route of the compounds in Examples 1-3 and the synthetic process schematic diagram of the AIE photosensitizer nanopolymer;

[0031] Figure 2 Schematic diagram of the synthesis process of the AIE photosensitizer nanopolymer in Example 1;

[0032] Figure 3 Schematic diagram of the synthesis process of the AIE photosensitizer nanopolymer in Example 2;

[0033] Figure 4 Schematic diagram of the synthesis process of the AIE photosensitizer nanopolymer in Example 3;

[0034] Figure 5 The fluorescence intensity increase graph and fluorescence effect graph of the compound obtained in step (1) of Example 2-3 in a dimethyl sulfoxide / water mixed solvent as the water content increases;

[0035] Figure 6 This is the size distribution diagram of the AIE photosensitizer nanopolymer prepared in Example 2-3 in aqueous solution;

[0036] Figure 7 UV-visible absorption spectra of DMTBSZ at different concentrations (A), concentration-absorption linear fitting relationship diagram of DMTBSZ (B), UV absorption spectra of DMTBSZ NPs after dilution 40 times (C), UV-visible absorption spectra of DMTBSeZ at different concentrations (D), concentration-absorption linear fitting relationship diagram of DMTBSeZ (E), and UV absorption spectra of DMTBSeZ NPs after dilution 40 times (F);

[0037] Figure 8 The graph of the change in fluorescence intensity after adding a photosensitizer to a DMSO / water solution containing H2DCF-DA probe, ABDA probe, DHR123 probe or HPF probe and irradiating the solution;

[0038] Fig. 9Fluorescence imaging of cell nucleus staining and co-staining of DMTBSZ NPs and Hoechst 33258 at different time points (A) and fluorescence imaging of cell nucleus staining and co-staining of DMTBSeZNPs and Hoechst 33258 at different time points (B);

[0039] Fig.10 Fluorescence imaging of cell lysosome staining and co-staining of DMTBSZ NPs and Lysotrackergreen DND-26 (A) and fluorescence imaging of cell lysosome staining and co-staining of DMTBSeZ NPs and Lyso-Tracker green DND-26 (B);

[0040] Fig.11 To evaluate the phototoxicity and dark toxicity of DMTBSZ NPs and DMTBSeZ NPs on 4T1 cells;

[0041] Fig.12 In vivo fluorescence imaging of mice after treatment with DMTBSZ NPs (A), comparison of tumor size in mice (B), tumor growth inhibition (C) and changes in mouse weight (D). DETAILED DESCRIPTION

[0042] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0043] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, the present invention is further described in detail below with reference to the accompanying drawings and specific embodiments.

[0044] The room temperature in the embodiments of the present invention refers to "25±2°C".

[0045] Unless otherwise specified, the raw materials in the examples of the present invention were purchased from commercial sources.

[0046] Example 1

[0047] A method for improving the efficiency of type I active oxygen of aggregation-induced emission photosensitizer, the specific steps are as follows:

[0048] (1) Synthesis of compound DTBSZ

[0049] The synthetic route of DTBSZ is:

[0050]

[0051] 4,7-Dibromo-2,1,3-benzothiazole (500 mg, 1.5 mmol), 4-boronic acid triphenylamine (980 mg, 3.4 mmol), Pd(PPh3)4 (68 mg, 0.06 mmol) and anhydrous potassium carbonate (2.0 g, 15 mmol) were added to a mixed solvent of tetrahydrofuran and water (the volume ratio of tetrahydrofuran and water was 25 mL:5 mL), and then refluxed at 100°C under nitrogen for 12 h. After the mixture was cooled, it was extracted three times with dichloromethane (DCM), then washed with brine, and the organic layer was dried over anhydrous sodium sulfate. Column chromatography was performed using DCM and petroleum ether (the volume ratio of DCM and petroleum ether was 1:30) as eluents to obtain purple-red powder DTBSZ (512 mg) with a yield of 56%.

[0052] The characterization data of the obtained DTBSZ are: 1 H NMR (400MHz, CD2Cl2) δ7.95-7.89(m,4H),7.78(s,2H),7.37-7.06(m,24H). 13 C NMR (101MHz, CD2Cl2) δ147.51(s), 129.94(s), 129.33(s), 127.31(s), 124.80(s), 123.30(s), 122.75(s), 53.68(s), 53.41(s), 53.14(s).

[0053] (2) Synthesis of DTBSZ NPs

[0054] DTBSZ (1.0 mg) obtained in step (1) and DSPE-PEG 2000 (2.0 mg) was fully dissolved in 1 mL of tetrahydrofuran, then placed in 10 mL of distilled water and ultrasonically treated for 5 min. The obtained solution was slowly stirred for 36 h until the tetrahydrofuran was removed to obtain a clear aqueous solution, namely the nanopolymer DTBSZ NPs.

[0055] Example 2

[0056] A method for improving the efficiency of type I active oxygen of aggregation-induced emission photosensitizer, the specific steps are as follows:

[0057] (1) Synthesis of compound DMTBSZ

[0058] The synthetic route of DMTBSZ is:

[0059]

[0060] 4,7-Dibromo-2,1,3-benzothiazole (500 mg, 1.5 mmol), 4-boric acid-4`,4`-dimethoxytriphenylamine (1.19 g, 3.4 mmol), Pd(PPh3)4 (68 mg, 0.06 mmol) and anhydrous potassium carbonate (2.0 g, 15 mmol) were added to a mixed solvent of tetrahydrofuran and water (the volume ratio of tetrahydrofuran and water was 25 mL:5 mL), and then refluxed at 100°C under nitrogen for 12 h. After the mixture was cooled, it was extracted three times with dichloromethane (DCM), then washed with brine, and the organic layer was dried over anhydrous sodium sulfate. Column chromatography was performed using DCM and petroleum ether (the volume ratio of DCM and petroleum ether was 1:30) as eluents to obtain purple-red powder DMTBSZ (610 mg) with a yield of 56%.

[0061] The characterization data of DMTBSZ obtained are: 1 H NMR (400MHz, CD2Cl2): δ7.82(d,J=8.8Hz,4H),7.70(s,2H),7.15-7.09(m,8H),7.01(d,J=8.8Hz,4H),6.91-6.84(m,8H),3.80(s,12H). 13 C NMR(101MHz,DMSO)δ127.49(s),115.49(s),55.72(s),41.04-40.71(m),40.50(d, J=20.7Hz), 40.33-40.26(m), 40.19(s), 39.88(d, J=20.6Hz), 39.56(s), 39.35(s).

[0062] (2) Synthesis of DMTBSZ NPs

[0063] DMTBSZ (1.0 mg) obtained in step (1) and DSPE-PEG 2000 (2.0 mg) was fully dissolved in 1 mL of tetrahydrofuran, then placed in 10 mL of distilled water and ultrasonically treated for 5 min. The obtained solution was slowly stirred for 36 h until the tetrahydrofuran was removed to obtain a clear aqueous solution, namely DMTBSZ NPs.

[0064] Example 3

[0065] A method for improving the efficiency of type I active oxygen of aggregation-induced emission photosensitizer, the specific steps are as follows:

[0066] (1) Synthesis of compound DMTBSeZ

[0067] The synthetic route of DMTBSeZ is:

[0068]

[0069] 4,7-Dibromo-2,1,3-benzoselenazole (500 mg, 1.5 mmol), 4-boric acid-4`,4`-dimethoxytriphenylamine (1.19 g, 3.4 mmol), Pd(PPh3)4 (68 mg, 0.06 mmol) and anhydrous potassium carbonate (2.0 g, 15 mmol) were added to a mixed solvent of tetrahydrofuran and water (the volume ratio of tetrahydrofuran and water was 25 mL:5 mL), and then refluxed at 100°C under nitrogen for 12 h. After the mixture was cooled, it was extracted three times with dichloromethane (DCM), then washed with brine, and the organic layer was dried over anhydrous sodium sulfate. Column chromatography was performed using DCM and petroleum ether (the volume ratio of DCM and petroleum ether was 1:30) as eluents to obtain purple-red powder DMTBSeZ (615 mg) with a yield of 53%.

[0070] The characterization data of the obtained DMTBSeZ are: 1 H NMR (400MHz, CD2Cl2) δ7.73 (d, J = 8.4Hz, 4H), 7.54 (s, 2H), 6.96 (dd, J = 72.4, 28.7Hz, 20H), 3.80 (s, 12H). 13 C NMR(101MHz,DMSO)δ127.31(s),115.46(s),55.71(s),41.95-40.95(m),40.51(d, J=19.9Hz), 40.19(s), 40.06-40.04(m), 39.88(d, J=21.0Hz), 39.56(s), 39.35(s).

[0071] (2) Synthesis of DMTBSeZ NPs

[0072] DMTBSeZ (1.0 mg) and DSPE-PEG 2000 (2.0 mg) was fully dissolved in 1 mL of tetrahydrofuran, then placed in 10 mL of distilled water and ultrasonically treated for 5 min. The resulting solution was slowly stirred for 36 h until the tetrahydrofuran was removed to obtain a clear aqueous solution, namely DMTBSeZ NPs.

[0073] Figure 1 The synthetic route of the compounds in Examples 1-3 and the schematic diagram of the synthetic process of AIE photosensitizer nanopolymer are shown.

[0074] Figure 2 Schematic diagram of the synthesis process of AIE photosensitizer nanopolymer in Example 1.

[0075] Figure 3Schematic diagram of the synthesis process of AIE photosensitizer nanopolymer in Example 2.

[0076] Figure 4 Schematic diagram of the synthesis process of AIE photosensitizer nanopolymer in Example 3.

[0077] Figure 5 The fluorescence intensity increase graph and fluorescence effect graph of the compound obtained in step (1) of Example 2-3 in a dimethyl sulfoxide / water mixed solvent as the water content increases, wherein (A) is the fluorescence intensity increase graph of DMTBSZ and DMTBSeZ, (B) is the fluorescence effect graph of DMTBSZ, and (C) is the fluorescence effect graph of DMTBSeZ. Figure 5 It can be seen that with the addition of poor solvent water, the fluorescence intensity of the two compounds is higher than that in pure dimethyl sulfoxide solvent, indicating that compounds DMTBSZ and DMTBSeZ both have AIE properties.

[0078] The size distribution of the AIE photosensitizer nanopolymer prepared in Example 2-3 was tested using a laser particle size analyzer. The results are shown in Figure 6 . Figure 6 The size distribution diagram of the AIE photosensitizer nanopolymer prepared in Example 2-3 in aqueous solution, wherein (A) is DMTBSZ NPs and (B) is DMTBSeZ NPs. Figure 6 It can be seen that the size of both photosensitizers is mainly concentrated around 135nm, indicating that they have a higher surface area to volume ratio, thus ensuring higher solubility and faster dissolution rate. Such small particles also have a longer circulation time in the bloodstream, and the permeability and retention effect in tumor tissues are enhanced.

[0079] Figure 7 UV-visible absorption spectra of DMTBSZ at different concentrations (A), concentration-absorption linear fitting relationship of DMTBSZ (B), UV absorption spectra of DMTBSZ NPs diluted 40 times (C), UV-visible absorption spectra of DMTBSeZ at different concentrations (D), concentration-absorption linear fitting relationship of DMTBSeZ (E), and UV absorption spectra of DMTBSeZ NPs diluted 40 times (F). Figure 7 The concentration of nanopolymers (DMTBSZ NPs and DMTBSeZ NPs) was obtained from the UV absorption spectrum of the nanopolymers, and then the encapsulation efficiency was calculated. It was finally concluded that the encapsulation efficiency of the two nanopolymers was greater than 40%, indicating that the AIE photosensitizer was effectively encapsulated by the amphiphilic nanopolymers, making drug delivery smoother.

[0080] Figure 8is a graph showing the amplitude of fluorescence intensity change after adding photosensitizer to DMSO / water solution containing H2DCF-DA probe, ABDA probe, DHR123 probe or HPF probe and irradiating it; wherein, (A) is a graph showing the amplitude of fluorescence intensity change after adding DMTBSZ and DMTBSZ NPs to DMSO / water solution containing H2DCF-DA probe and irradiating it, λ ex =488nm; (B) is the absorption intensity change amplitude diagram after adding DMTBSZ, DMTBSeZ, DMTBSZ NPs and DMTBSeZ NPs to the solution containing ABDA probe, λ abs =400nm; (C) is a graph showing the fluorescence intensity change amplitude after adding DMTBSZ, DMTBSeZ, DMTBSZ NPs and DMTBSeZ NPs to a DMSO / water solution containing DHR123 probe, λ ex =490nm; (D) is a graph showing the fluorescence intensity change amplitude after adding DMTBSZ and DMTBSZ NPs to a DMSO / water solution containing a HPF probe, λ ex =490nm. Figure 8 As can be seen in part (A), the overall ROS efficiency of the small molecule compound DMTBSZ is significantly improved after it is co-assembled with the polymer to form nanoparticles, indicating that the co-assembly strategy of the amphiphilic polymer and the AIE active photosensitizer not only provides better water dispersibility, but also helps to improve the efficiency of the photosensitizer in generating ROS. Figure 8 It can be seen from part (B) that after the compounds DMTBSZ and DMTBSeZ are co-assembled with polymers to form nanoparticles, the singlet oxygen generated by light is generally suppressed. Singlet oxygen is a reactive oxygen species generated by triplet energy transfer between the photosensitizer and oxygen. After the polymer encapsulates the AIE photosensitizer, multiple interactions (π-π stacking, electrostatic interactions, etc.) exist between the two components, which weaken the originally weak energy transfer ability, so the singlet oxygen generation ability of the nanopolymer photosensitizer is suppressed. Figure 8 As can be seen in part (C), the efficiency of generating superoxide anions by light is greatly improved after the compounds DMTBSZ and DMTBSeZ are co-assembled with polymers to form nanoparticles. Under light irradiation, the photosensitizer that intersystem crosses to the triplet excited state transfers an electron to the surrounding oxygen to generate superoxide anions, a reactive oxygen species with free radical properties. After the polymer encapsulates the AIE photosensitizer, due to the presence of a large number of heteroatoms such as oxygen, phosphorus, and nitrogen in the polymer shell, this helps the photosensitizer to sensitize the electron transfer to generate superoxide anion free radicals. Figure 8As can be seen in part (D), for the small molecule compound DMTBSZ, the efficiency of generating hydroxyl radicals is improved after it is co-assembled with a polymer to form nanoparticles, indicating that polymer coating can enhance the ability of the photosensitizer to generate hydroxyl radical-type reactive oxygen species.

[0081] Mouse cancer 4T1 cells were cultured in culture medium for 24 h, and then 5 μM DMTBSZNPs, 10 μM Hoechst 33258 (specific DNA dye), 5 μM DMTBSeZNPs, 5 μM DMTBSZ NPs and 0.2 μM Hoechst 33258 in PBS, and 5 μM DMTBSeZ NPs and 0.2 μM Hoechst 33258 in PBS were added to the culture medium, respectively. After being exposed to water at 37°C for 2 h, 4 h, and 6 h, the cells were washed three times with PBS and imaged using a laser confocal microscope. The results are shown in Figure 2. Fig. 9 .

[0082] Fig. 9 Figure 2 shows the fluorescence images of cell nucleus staining and co-staining of DMTBSZ NPs and Hoechst 33258 at different time points (A) and the fluorescence images of cell nucleus staining and co-staining of DMTBSeZNPs and Hoechst 33258 at different time points (B), where [DMTBSZNPs] = 5 μM, λ ex =490nm,λ em =550-700nm; [DMTBSeZ NPs] =5μM, λ ex =510nm,λ em =550-700nm; [Hoechst 33258] =10μM, λ ex =350nm,λ em =370-500nm, scale bar = 50μm. Fig. 9 As can be seen from the results, in 4T1 cells, NPs emitted weak red fluorescence after 4 h, indicating that NPs were internalized by cells. As the incubation time was extended to 6 h, the red fluorescence became stronger, indicating that NPs accumulated in 4T1 cells.

[0083] Mouse cancer 4T1 cells were cultured in culture medium for 24 h, and then 5 μM DMTBSZNPs, 200 nM Lyso-Tracker Green DND-26 (lysosomal green fluorescent probe), 5 μM DMTBSeZNPs, 5 μM DMTBSZ NPs and 200 nM Lyso-Tracker Green DND-26 in PBS, and 5 μM DMTBSeZ NPs and 200 nM Lyso-Tracker Green DND-26 in PBS were added to the culture medium, respectively. After incubation at 37°C for 24 h, the cells were washed three times with PBS, and imaging was performed using a laser confocal microscope. The results are shown in Figure 2. Fig.10 .

[0084] Fig.10 Fluorescence imaging of cell lysosome staining and co-staining of DMTBSZ NPs and Lysotracker green DND-26 (A) and fluorescence imaging of cell lysosome staining and co-staining of DMTBSeZ NPs and Lyso-Tracker green DND-26 (B), where [DMTBSZ NPs] = 5 μM, λ ex =490nm,λ em =550-700nm; [DMTBSeZ NPs] =5μM, λ ex =510nm,λ em =550-700nm; [Lyso-Trackergreen DND-26] =200nM, λ ex =488nm,λ em = 500-550nm, scale bar = 50μm. Fig.10 As can be seen from the results, the red fluorescence of NPs and the green fluorescence of Lyso-Tracker highly overlap, indicating that NPs are aggregated in lysosomes.

[0085] Mouse cancer 4T1 cells were grown in a confocal imaging dish at 37°C under normal conditions. After incubating the cells with complete medium for 12 h, the complete medium was replaced with drug-containing medium at a drug concentration of 20 μM and incubated for another 12 h. The cells were exposed to 30 mW cm -2 The cells were irradiated with white light for 30 min and further incubated at 37 °C for 12 h. Then, the cells were treated with 20 μM calcein (a live cell dye) and 2 μg mL -1 The culture medium was stained with ethidium bromide dimer 1 (dead cell dye) for 30 minutes, and the stained cells were imaged using a laser confocal microscope. The results are shown in Fig.11 Among them, the cell incubation scheme is as follows:

[0086] ① DMTBSZNPs illumination group: drug-containing medium plus DMTBSZNPs, incubation condition is illumination;

[0087] ②DMTBSeZNPs illumination group: drug-containing medium plus DMTBSeZNPs, incubation condition is illumination;

[0088] ③DMTBSZNPs group: drug-containing medium plus DMTBSZ NPs, incubation conditions without light;

[0089] ④DMTBSeZNPs group: drug-containing medium plus DMTBSeZ NPs, incubation conditions without light;

[0090] ⑤Blank group: culture medium plus physiological saline, incubation condition is light.

[0091] Fig.11 The phototoxicity and dark toxicity evaluation of DMTBSZ NPs and DMTBSeZ NPs on 4T1 cells; wherein [calcein] = [ethidium bromide dimer 1] = 5 μM. Fig.11 It can be seen that the cells cultured with NPs were stained with dead cell dyes on a large scale after light treatment, while the cells without light treatment remained active, indicating that DMTBSZ NPs and DMTBSeZNPs have good cellular phototoxicity and almost no biological dark toxicity to cells, showing good photodynamic therapy effects.

[0092] Using 4T1 mouse breast cancer cells as a model, they were implanted subcutaneously on the right back of the mouse to establish a tumor animal model. When the subcutaneous tumor size of the mouse was 100 mm 3 Afterwards, the drug was injected intratumorally twice on the 1st and 7th days, and 200 mW cm -2 White light therapy was performed by irradiating the mice with white light for 20 minutes. After the treatment period (14 days), the changes in tumor volume and body weight of the mice were recorded every two days. The results are shown in Fig.12 Among them, the treatment options are as follows:

[0093] ① DMTBSZ NPs light irradiation group: injection of DMTBSZ NPs, the dosage was 100 μL, the concentration was 100 μM, and white light treatment was performed;

[0094] ②PBS illumination group: injected with PBS, the dosage was 100 μL, the concentration was 100 μM, and white light treatment was performed;

[0095] ③DMTBSZ NPs without light treatment group: injection of DMTBSZ NPs, the dosage was 100 μL, the dosage concentration was 100 μM, and no white light treatment was performed;

[0096] ④Blank group: injected with normal saline, the dosage was 100 μL, the drug concentration was 100 μM, and white light treatment was performed.

[0097] Fig.12 In vivo fluorescence imaging of mice after exposure to DMTBSZ NPs (A), comparison of tumor size in mice (B), tumor growth inhibition (C), and weight changes of mice (D). Fig.12 As can be seen in part (A), after injecting DMTBSZ NPs into the tumor for 2 hours, the in vivo fluorescence imaging was obvious and the signal-to-noise ratio was low, indicating that the photosensitizer has a good in vivo fluorescence imaging effect. Fig.12 As can be seen in parts (B) and (C), the tumors in the DMTBSZ NPs group that were not irradiated with light and not treated with photodynamic therapy proliferated rapidly, but after photodynamic therapy, the growth of the tumors could be effectively inhibited, indicating that DMTBSZ NPs still have a good effect in the treatment of in vivo tumors. Fig.12 Part (D) shows that the weight gain trend of mice in all experimental groups was the same, indicating that the mice in the DMTBSZ NPs irradiation group under photodynamic therapy did not have tumor growth inhibition due to other reasons.

[0098] The above are only preferred specific implementations of the present application, but the protection scope of the present application is not limited thereto. Any changes or substitutions that can be easily thought of by a person skilled in the art within the technical scope disclosed in the present application should be included in the protection scope of the present application. Therefore, the protection scope of the present application should be based on the protection scope of the claims.

Claims

1. A method for improving the efficiency of type I active oxygen in aggregation-induced emission photosensitizers, characterized in that: The following steps are involved: (1) dissolving 4,7-dibromo-2,1,3-benzothiadiazole or 4,7-dibromo-2,1,3-benzoselenadiazole with a triphenylamine derivative, a catalyst and a base in a mixed solution of an organic solvent and water to carry out a Suzuki reaction, followed by refluxing, extraction, washing, drying and column chromatography to obtain an aggregation-induced emission photosensitizer; (2) dissolving the aggregation-induced emission photosensitizer and the amphiphilic polymer liposome obtained in step (1) in an organic solvent to obtain a mixed solution; mixing the obtained mixed solution with water, performing ultrasonic treatment, and then stirring and filtering to obtain an AIE photosensitizer nanopolymer.

2. The method for improving the efficiency of type I active oxygen of aggregation-induced emission photosensitizer according to claim 1, characterized in that: In step (1), the molar ratio of the 4,7-dibromo-2,1,3-benzothiadiazole or 4,7-dibromo-2,1,3-benzoselenadiazole to the triphenylamine derivative, the catalyst and the base is (1-1.5):(2-4):(0.05-0.1):

15.

3. The method for improving the efficiency of type I active oxygen of aggregation-induced emission photosensitizer according to claim 1 or 2, characterized in that: In step (1), the triphenylamine derivative includes one of 4-boric acid triphenylamine and 4-boric acid-4',4'-dimethoxytriphenylamine.

4. The method for improving the efficiency of type I active oxygen of aggregation-induced emission photosensitizer according to claim 1, characterized in that: In step (1), the catalyst is tetrakistriphenylphosphine palladium; and the base is one of K2CO3 and Na2CO3.

5. The method for improving the efficiency of type I active oxygen of aggregation-induced emission photosensitizer according to claim 1, characterized in that: In step (1), the temperature of the Suzuki reaction is 80-100° C. and the time is 10-14 h.

6. The method for improving the efficiency of type I active oxygen of aggregation-induced emission photosensitizer according to claim 1, characterized in that: In step (2), the mass ratio of the aggregation-induced emission photosensitizer to the amphiphilic polymer liposome is 1:

2.

7. The method for improving the efficiency of type I active oxygen of aggregation-induced emission photosensitizer according to claim 1, characterized in that: In step (2), the stirring time is 36 hours.

8. The method for improving the efficiency of type I active oxygen of aggregation-induced emission photosensitizer according to claim 1, characterized in that: In step (2), the volume ratio of the organic solvent to water is 1:

10.

9. An AIE photosensitizer nanopolymer, characterized in that: The method for improving the efficiency of type I active oxygen of aggregation-induced emission photosensitizer according to any one of claims 1 to 8 is used to prepare the photosensitizer.

10. Use of the AIE photosensitizer nanopolymer according to claim 9 in the preparation of drugs for treating tumors.

Citation Information

Patent Citations

  • Self-doped conjugated phenolamine hole-transporting material and its preparation method and use

    CN106397355A

  • Application of aggregation-induced emission photosensitizer in preparation of ferroptosis inducer

    CN114656398A

  • Preparation method of aggregation-induced emission microspheres with core-shell structure

    CN114672301A

  • Benzoselenadiazole derivative as well as preparation method and application thereof

    CN117126156A

  • Nanometer red light AIE photosensitizer drug delivery system for photodynamic diagnosis and treatment

    CN117899050A